Vertex Pharmaceuticals Incorporated
時価総額
$130.6B
世界順位
#131
過去最高値
$134.4B
2026-07-06
総成長率
+0%
2026年以降
Market Cap Context
- Larger than 64% of the 367 companies we track (globally).
- Equivalent to 0.4% of United States's GDP (2025 data).
- Just above: #130 Bank of Montreal ($131.4B)
- Just below: #132 Stryker Corporation ($127.2B)
- Best year: 2000 (+309%). Worst year: 2001 (-66%).
Vertex Pharmaceuticals Incorporated Financial Breakdown (FY 2025)
Source: Yahoo Finance — VRTX annual filings (2025) →$12.0B revenue · $4.6B operating income · $4.0B net income
- ●Operating margin: 37.9% on $12.0B in revenue.
- ●R&D is 33.7% of revenue ($4.0B).
- ●Net income margin: 32.9% — $4.0B in profit.
- ●Free cash flow: $3.2B (26.6% of revenue).
Cost / Operating Expenses
Total operating expenses $7.4B
Total
$7.4B
Capital Expenditures
$0.4B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$3.2B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
Vertex Pharmaceuticals Incorporatedについて
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.
Vertex Pharmaceuticals Incorporatedの時価総額推移 (2026–2026)
Vertex Pharmaceuticals Incorporated vs Sector Peers by Market Cap
Vertex Pharmaceuticals Incorporatedを比較
順位の推移
| 年 | 時価総額 | 順位 | 前年比 |
|---|---|---|---|
| 2026 | $130.6B | #131(↑5) | +13.5% |
| 2025 | $115.1B | #136(↓7) | +12.6% |
| 2024 | $102.2B | #129(↓21) | -1.0% |
| 2023 | $103.3B | #108(↑17) | +40.9% |
| 2022 | $73.3B | #125(↑57) | +31.5% |
| 2021 | $55.7B | #182(↓39) | -7.1% |
| 2020 | $60.0B | #143(↓18) | +7.9% |
| 2019 | $55.6B | #125(↑3) | +32.1% |
| 2018 | $42.1B | #128(↑24) | +10.6% |
| 2017 | $38.0B | #152(↑70) | +103.4% |
| 2016 | $18.7B | #222(↓94) | -41.5% |
| 2015 | $31.9B | #128(↑2) | +5.9% |
| 2014 | $30.2B | #130(↑44) | +59.9% |
| 2013 | $18.9B | #174(↑28) | +77.3% |
| 2012 | $10.6B | #202 | +26.2% |
| 2011 | $8.4B | #202(↑4) | -5.2% |
| 2010 | $8.9B | #206(↓37) | -18.2% |
| 2009 | $10.9B | #169(↓4) | +41.0% |
| 2008 | $7.7B | #165(↑62) | +30.8% |
| 2007 | $5.9B | #227(↓49) | -37.9% |
| 2006 | $9.5B | #178(↑9) | +35.2% |
| 2005 | $7.0B | #187(↑43) | +161.8% |
| 2004 | $2.7B | #230(↓16) | +2.1% |
| 2003 | $2.6B | #214(↓54) | -34.7% |
| 2002 | $4.0B | #160(↓22) | -35.5% |
| 2001 | $6.2B | #138(↓69) | -65.6% |
| 2000 | $18.1B | #69(↑51) | +308.6% |
| 1999 | $4.4B | #120(↓2) | +17.6% |
| 1998 | $3.8B | #118(↓14) | -9.8% |
| 1997 | $4.2B | #104(↓35) | -18.0% |
| 1996 | $5.1B | #69(↑9) | +51.9% |
| 1995 | $3.4B | #78(↑1) | +76.7% |
| 1994 | $1.9B | #79 |
その他のヘルスケア企業
よくある質問
What is Vertex Pharmaceuticals Incorporated's market cap?
Vertex Pharmaceuticals Incorporated (VRTX) has a market capitalization of $130.6B, making it the #131 largest company in the world by market cap.
What was Vertex Pharmaceuticals Incorporated's highest market cap?
Vertex Pharmaceuticals Incorporated's all-time high market cap was $134.4B, reached in 2026-07-06. Its highest rank was #131 in 2026.
What sector is Vertex Pharmaceuticals Incorporated in?
Vertex Pharmaceuticals Incorporated is in the Healthcare sector, specifically the Biotechnology industry. It is based in United States.
How has Vertex Pharmaceuticals Incorporated's market cap changed over time?
Vertex Pharmaceuticals Incorporated has been tracked since 2026. Its market cap has grown by 0% from $130.6B in 2026 to $130.6B today.